- Home
- XBIO vs INTZ Comparison
XBIO vs INTZ Comparison
Compare XBIO & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- INTZ
- Stock Information
- Founded
- XBIO N/A
- INTZ 1983
- Country
- XBIO United States
- INTZ United States
- Employees
- XBIO N/A
- INTZ N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- INTZ Computer Communications Equipment
- Sector
- XBIO Health Care
- INTZ Telecommunications
- Exchange
- XBIO Nasdaq
- INTZ Nasdaq
- Market Cap
- XBIO 5.8M
- INTZ 4.9M
- IPO Year
- XBIO N/A
- INTZ 2020
- Fundamental
- Price
- XBIO $3.66
- INTZ $0.67
- Analyst Decision
- XBIO Hold
- INTZ Buy
- Analyst Count
- XBIO 1
- INTZ 2
- Target Price
- XBIO N/A
- INTZ $45.50
- AVG Volume (30 Days)
- XBIO 30.0K
- INTZ 144.1K
- Earning Date
- XBIO 11-12-2024
- INTZ 11-12-2024
- Dividend Yield
- XBIO N/A
- INTZ N/A
- EPS Growth
- XBIO N/A
- INTZ N/A
- EPS
- XBIO N/A
- INTZ N/A
- Revenue
- XBIO $2,523,427.00
- INTZ $5,461,000.00
- Revenue This Year
- XBIO N/A
- INTZ $14.53
- Revenue Next Year
- XBIO N/A
- INTZ $53.33
- P/E Ratio
- XBIO N/A
- INTZ N/A
- Revenue Growth
- XBIO 7.15
- INTZ N/A
- 52 Week Low
- XBIO $2.78
- INTZ $0.65
- 52 Week High
- XBIO $5.20
- INTZ $8.20
- Technical
- Relative Strength Index (RSI)
- XBIO 45.78
- INTZ 40.16
- Support Level
- XBIO $3.58
- INTZ $0.69
- Resistance Level
- XBIO $4.60
- INTZ $0.90
- Average True Range (ATR)
- XBIO 0.41
- INTZ 0.06
- MACD
- XBIO -0.02
- INTZ 0.00
- Stochastic Oscillator
- XBIO 7.48
- INTZ 4.42
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. It is engaged in developing, marketing, and supporting a group of entity identification, high-speed data mining, cybercrime, and persistent threat detection products. The company's product consists of TraceCop which is for identity discovery and disclosure, Savant for network data mining and persistent threat detection, and Compliance Commander which is for regulated information and data privacy protection. In addition, its products are used by various customers including banks, credit unions, other financial institutions, United States federal government entities, foreign government entities, hospitals, and other healthcare providers.